Interaction Guide · Research summary

Can I take Radix Et Rhizoma Valerianae with Oxazepam?

Review Radix Et Rhizoma Valerianae with Oxazepam: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Identify the valerian species and preparation before using this root product with oxazepam. Comparisons of a specific valerian extract with oxazepam do not establish safety of the combination.

What this answer covers

Unresolved Radix et Rhizoma Valerianae species; V. officinalis guidance and LI 156 extract evidence apply only to matched products.

Supplement or preparation
Radix et Rhizoma Valerianae
Medication ingredient
oxazepam

Resolve the botanical identity

Ask for the Latin species, plant part and extract on the label. The name valerian root by itself does not establish Valeriana officinalis or the preparation tested in a trial.

What the six-week study showed

One trial compared a specific valerian extract with oxazepam for insomnia. Both groups improved, but participants did not take the two active treatments together. Similar outcomes do not establish combination safety.

A matching species still needs review

For confirmed Valeriana officinalis, NCCIH advises against use with sedatives. No validated spacing rule makes an unknown root product safe with oxazepam.

Protect your alertness

Oxazepam can impair coordination and alertness. Avoid driving when affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about all other sedating medicines and alcohol.

Evidence and practical considerations

Side effects & toxicity

Unidentified-root avoidance/sedation claims remain insufficient; conditional species-matched sedative caution is appropriate after identification.

Exact scope
Unresolved Radix et Rhizoma Valerianae species; V. officinalis guidance and LI 156 extract evidence apply only to matched products. with Exact oral oxazepam; no blanket benzodiazepine metabolic or route transfer.
Medication form and route
oral; other cannabis routes only if explicitly discussed
Timing or duration
Exact duration and dose depend on source; single-dose and chronic use are distinguished.

What remains uncertain

  • No exact unidentified-root co-use trial. Comparator trial used separate active treatments and lacked a combined group.

Factors that may matter: preparation and plant part; dose; other medicines; baseline alertness; clinical indication.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral oxazepam.

CNS depression, impaired coordination and alertness can occur; concomitant CNS depressants require caution. Dependence and withdrawal risks require individualized tapering rather than abrupt cessation. A single major inactive glucuronide metabolite is excreted in urine. CYP3A interactions measured with alprazolam cannot simply be assigned to oxazepam.

How this applies: Exact RxNorm ingredient and oral formulation confirmed in original label; use exact indication and metabolic boundaries.

Does not quantify the requested botanical interaction risks, prove every herb is sedating, or establish a protective supplement interval.

Source 2: official guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: People considering the specified supplement.

Possible but unproven sleep-inducing effect; advises against use with alcohol or sedatives. Mental dullness can occur; long-term safety is uncertain.

How this applies: Preparation-specific context; not a directly measured oxazepam interaction.

No oxazepam interaction trial. Chronic use can be followed by withdrawal symptoms when stopped abruptly.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 202 outpatients with insomnia.

Sleep quality improved in both groups; adverse events were mild to moderate in both.

How this applies: Apply only to exact medication, preparation and study exposure; comparator treatment is not co-use.

No placebo-only arm or co-use group. Specific valerian extract does not identify an unspecified root product.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact claims adjudicated against captured originals and explicit comparator/co-use boundaries.
Research summary published

Article revision: 605cfbb80eda50bd

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.